Skandinaviska Enskilda Banken (SEB)’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-108,300
| Closed | -$1.65M | – | 785 |
|
|
2018
Q4 | $1.65M | Buy |
108,300
+13,300
| +14% | +$202K | 0.01% | 536 |
|
|
2018
Q3 | $1.9M | Buy |
+95,000
| New | +$1.9M | 0.01% | 511 |
|
|
2018
Q2 | – | Sell |
-121,200
| Closed | -$2.44M | – | 748 |
|
|
2018
Q1 | $2.44M | Sell |
121,200
-59,000
| -33% | -$1.19M | 0.02% | 349 |
|
|
2017
Q4 | $2.39M | Buy |
180,200
+22,800
| +14% | +$302K | 0.02% | 403 |
|
|
2017
Q3 | $2.9M | Sell |
157,400
-8,300
| -5% | -$153K | 0.03% | 387 |
|
|
2017
Q2 | $3.05M | Buy |
165,700
+7,100
| +4% | +$131K | 0.03% | 381 |
|
|
2017
Q1 | $3.58M | Buy |
158,600
+49,700
| +46% | +$1.12M | 0.04% | 339 |
|
|
2016
Q4 | $3.79M | Sell |
108,900
-66,600
| -38% | -$2.32M | 0.05% | 271 |
|
|
2016
Q3 | $4.3M | Sell |
175,500
-36,500
| -17% | -$895K | 0.05% | 283 |
|
|
2016
Q2 | $5.07M | Buy |
212,000
+8,900
| +4% | +$213K | 0.06% | 246 |
|
|
2016
Q1 | $4.75M | Sell |
203,100
-37,100
| -15% | -$868K | 0.05% | 251 |
|
|
2015
Q4 | $7.33M | Buy |
+240,200
| New | +$7.33M | 0.09% | 162 |
|